C

    China SXT Pharmaceuticals Inc (SXTC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $2.56
    -0.44 (-14.67%)

    Market Cap: $1.60M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    		$N/AN/AN/ABeat-
    Sep 25
    		$-0.05$0.00N/AMiss+75.0%
    Jun 25
    		$-1.02$0.00N/AMiss-277.8%
    Dec 24
    		$-1.99$0.00N/AMiss-2090.0%
    Jun 22
    		$-2.03$0.00N/AMiss-1425.2%
    Dec 21
    		$-0.20$0.00N/AMiss+52.4%
    Jun 21
    		$-0.27$0.00N/AMiss-170.0%
    Dec 20
    		$0.10$0.00N/ABeat+116.8%
    Sep 20
    		$-0.13$0.00N/AMiss+77.6%
    Jun 20
    		$-0.42$0.00N/AMiss-700.0%
    Mar 20
    		$-0.10$0.00N/AMiss+51.6%
    Dec 19
    		$-0.59$0.00N/AMiss-1288.0%
    Sep 19
    		$-0.59$0.00N/AMiss-6040.0%
    Jun 19
    		$0.07$0.00N/ABeat-29.6%
    Mar 19
    		$-0.21$0.00N/AMiss-616.5%
    Dec 18
    		$0.05$0.00N/ABeat+38.9%
    Sep 18
    		$0.01$0.00N/ABeat-87.2%
    Jun 18
    		$0.10$0.00N/ABeat+27.6%
    Mar 18
    		$0.04$0.00N/ABeat-46.7%
    Dec 17
    		$0.04$0.00N/ABeat-
    Jun 17
    		$0.08$0.00N/ABeat-
    Mar 17
    		$0.08$0.00N/ABeat-
    Dec 16
    		$0.07$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.00EV/EBITDA7.08x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-153.30%
    ROE-27.50%ROIC-23.88%
    Financial Health
    Debt/Equity0.01xInterest Coverage-27.39x
    Current Ratio7.93xQuick Ratio7.25x
    Trading Statistics
    Beta1.89Avg Volume43.51M
    52-Week High$311.6852-Week Low$0.04

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.74
    SMA 20$4.12
    SMA 50$88.35
    SMA 200$3624.26
    EMA 10$4.20
    EMA 20$15.28
    EMA 50$89.52
    EMA 200$4813.93

    MACD

    Line: -19.93Signal: -25.84Hist: 5.91

    ADX

    ADX: 44.4+DI: 0.8-DI: 0.6

    Aroon & PSAR

    Aroon Up64.0
    Aroon Down36.0
    PSAR$5.55

    Bollinger Bands

    Upper Band$7.13
    Lower Band$1.10
    %B Position14634%(Upper)
    Band Width0.24

    RSI (14-Day)

    Oversold
    24.6

    Momentum Oscillators

    Stoch %K4.9
    Stoch %D26.2
    Williams %R-99.9
    ROC (10d)-31.7%
    Momentum-1.19
    CCI (20d)-65.2
    MFI (14d)94.7

    Volatility Measures

    ATR (14d)$26.48(1034.5%)
    StdDev (20d)1.51
    Hist Vol363.8%(High)

    Volume Flow

    VWAP$2.72
    OBV1.2B
    AD Line92898.1B
    CMF (20d)483.423

    Volume Metrics

    Avg Vol (20d)24.0M
    Vol Ratio0.0x(Low)
    VWMA (20d)$6.57

    Pivot Points

    R3$3.57
    R2$3.45
    R1$3.23
    Pivot Point$3.11
    S1$2.89
    S2$2.77
    S3$2.55

    Advanced Oscillators

    TSI-51.31
    Ultimate Osc31.0
    KST-603.83

    Financial Data

    QuarterJun 2026Dec 2025Sep 2025Jun 2025Dec 2024Jun 2024Dec 2023Sep 2023Jun 2023Dec 2022Sep 2022Jun 2022
    Total Revenue$1.20M$255,741$626,570$455,709$455,709$414,745$751,073$898,163$469,791$381,696$1.21M$-11,502,270
    Cost of Revenue$364,502$182,251$524,848$339,372$339,372$347,368$361,642$753,992$325,621$213,402$1.12M$4.03M
    Gross Profit$833,974$73,490$101,722$116,337$116,337$67,377$389,431$144,171$144,170$168,294$89,684$-15,530,475
    Operating Expenses$1.62M$465,494$6.44M$1.14M$1.14M$386,511$-3,027,471$4.82M$4.82M$2.40M$1.24M$8.44M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$686,991$362,713$6.44M$1.02M$1.02M$361,199$3.62M$4.73M$4.73M$2.16M$483,982$2.20M
    Operating Income$-784,008$-392,004$-6,338,925$-1,021,106$-1,021,106$-319,134$3.42M$-4,674,510$-4,674,511$-2,228,532$-1,150,450$1.28M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$31,640$15,820$31,325$232,875$232,875$91,236$103,880$336,520$92,490$0$384,286$3.56M
    Income Before Tax$-1,210,267$81,858$-6,368,803$-1,250,542$-1,250,542$-401,284$2.79M$-90,728$-4,842,769$-2,220,081$-747,300$2.38M
    Income Tax Expense$-1,373,985$0$0$0$0$-10,921,232$-513,232$4.76M$5,310$0$4$-596,164
    Net Income$163,718$81,858$-6,368,803$-1,250,542$-1,250,542$-401,284$3.30M$-4,848,079$-4,848,079$-2,220,081$-1,494,609$2.32M
    EBITDA$-672,889$-371,221$-6,306,825$-1,014,227$-1,014,227$-284,864$3.68M$-4,623,135$-4,623,136$-1,983,739$-520,240$4.99M
    EBIT$-784,008$-392,005$-6,338,925$-1,021,106$-1,021,106$-319,134$3.63M$-4,674,510$-4,674,511$-2,053,837$-575,223$5.28M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SXTC

    News

    SXTC Stock Rockets On Momentum As Balance Sheet Shines

    China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) has experienced a significant stock surge, rising by 27.47% due to positive market sentiment and strong buying interest. The company's balance sheet reveals approximately $28 million in cash and minimal debt, providing a substantial liquidity cushion. Despite low revenue, its price-to-book ratio around 0.07 suggests the market heavily discounts its stated book value, making it an attractive, albeit volatile, option for momentum traders.

    Timothy Sykes•8/18/26•
    Bullish

    SXTC Stock Rockets On Ultra-Low Float Volatility Spike

    China SXT Pharmaceuticals Inc. (SXTC) stock has surged by 48.84%, driven by strong momentum and low-float volatility. Despite weak profitability, the company's strong cash position and low price-to-book ratio have made it an attractive target for speculative traders, leading to significant price swings. Traders are closely monitoring key support and resistance levels as SXTC transitions from a quiet penny stock to a highly volatile trading play.

    StocksToTrade•8/18/26•
    Bullish

    Top movers in Tuesday's pre-market session

    This article details the top pre-market gainers and losers on Tuesday, August 18, 2026. It highlights significant stock movements for companies like XOS, PROFUSA, WETOUR ROBOTICS, and SINGULARITY FUTURE TECHNOLOG among gainers, and NETCAPITAL, SYNERGY CHC, UCLOUDLINK GROUP, and KLARNA GROUP among losers, often referencing recent news or previous day's performance.

    ChartMill•8/18/26•
    Neutral

    SXTC Stock Rockets On Massive Reverse Split Volatility

    China SXT Pharmaceuticals Inc. (SXTC) stock experienced a significant surge, trading up by 28.78% due to a reverse split that reset its share structure and attracted momentum traders. Despite strong cash reserves and low debt, the company faces profitability issues, leading to a distressed valuation. Traders are focusing on SXTC's volatile chart patterns, which show aggressive buying and selling, making it a high-risk, pure price-action play.

    StocksToTrade•8/18/26•
    Somewhat-Bullish

    SXTC Stock Rockets On Reverse Split And Volatility Wave

    China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) has experienced a significant stock surge of over 25% due to a reverse split and heightened investor interest. Despite a healthy balance sheet with substantial cash and low debt, the company's price-to-book ratio is very low, indicating market skepticism about its reported asset value and earnings power. This has created a highly volatile trading environment, making SXTC a focus for short-term traders seeking momentum.

    StocksToTrade•8/18/26•
    Bullish

    Frequently Asked Questions About SXTC

    Does SXTC pay dividends?
    China SXT Pharmaceuticals Inc (SXTC) does not currently pay a regular dividend.
    What is SXTC's market cap?
    China SXT Pharmaceuticals Inc (SXTC) has a market capitalization of $1.60M with a current stock price of $2.56.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In